Daily Low-dose Aspirin May Increase Mortality Risk in Older Cancer Patients
In a recent article, researchers examined correlations between daily use of low-dose aspirin and increased risk of advanced forms of cancer and metastasis in older adults. In contrast to previous randomized, controlled trials that showed a delayed, but beneficial, effect of low-dose aspirin on cancer observed in younger patients, the current research team analyzed the incidence of cancer and associated mortality in older patients who received low-dose aspirin. Read more. |